Seizert Capital Partners LLC Sells 291 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Seizert Capital Partners LLC lessened its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 7.5% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,572 shares of the medical instruments supplier’s stock after selling 291 shares during the period. Seizert Capital Partners LLC owned 0.10% of Utah Medical Products worth $342,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of America Corp DE lifted its position in Utah Medical Products by 132.2% during the fourth quarter. Bank of America Corp DE now owns 2,190 shares of the medical instruments supplier’s stock worth $182,000 after purchasing an additional 1,247 shares during the period. Dimensional Fund Advisors LP lifted its position in Utah Medical Products by 1.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 175,614 shares of the medical instruments supplier’s stock worth $14,590,000 after purchasing an additional 2,336 shares during the period. Mercer Global Advisors Inc. ADV bought a new stake in Utah Medical Products during the first quarter worth about $224,000. BNP Paribas Arbitrage SA lifted its position in Utah Medical Products by 428.7% during the first quarter. BNP Paribas Arbitrage SA now owns 719 shares of the medical instruments supplier’s stock worth $63,000 after purchasing an additional 583 shares during the period. Finally, Rice Hall James & Associates LLC lifted its position in Utah Medical Products by 90.8% during the first quarter. Rice Hall James & Associates LLC now owns 44,989 shares of the medical instruments supplier’s stock worth $3,970,000 after purchasing an additional 21,407 shares during the period. 78.83% of the stock is owned by institutional investors and hedge funds.

UTMD traded down $3.35 on Friday, hitting $89.70. 7,513 shares of the stock were exchanged, compared to its average volume of 11,742. Utah Medical Products, Inc. has a 12 month low of $73.98 and a 12 month high of $102.70. The business has a 50-day moving average of $90.35 and a two-hundred day moving average of $86.94. The firm has a market capitalization of $346.11 million, a price-to-earnings ratio of 25.35 and a beta of 0.83.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, October 3rd. Investors of record on Friday, September 13th will be given a dividend of $0.275 per share. The ex-dividend date of this dividend is Thursday, September 12th. This represents a $1.10 annualized dividend and a yield of 1.23%.

Separately, BidaskClub cut shares of Utah Medical Products from a “buy” rating to a “hold” rating in a research report on Tuesday, August 20th.

Utah Medical Products Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry in the United States, Europe, and internationally. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD, an infant respiratory hood; and DELTRAN PLUS, a blood pressure monitoring system.

Recommended Story: Ex-Dividend

Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMD).

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.